Global Wealth Management Investment Advisory’s ARK Genomic Revolution ETF ARKG Stock Holding History

Global Wealth Management Investment Advisory’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5	Closed	-$170	–	479
2023 Q2	$170	Buy	+5	New	+$157	﹤0.01%	462
2022 Q3	–	Sell	-107	Closed	-$3K	–	159
2022 Q2	$3K	Hold	107	–	–	﹤0.01%	368
2022 Q1	$5K	Hold	107	–	–	﹤0.01%	359
2021 Q4	$7K	Hold	107	–	–	﹤0.01%	333
2021 Q3	$8K	Hold	107	–	–	﹤0.01%	330
2021 Q2	$10K	Hold	107	–	–	﹤0.01%	290
2021 Q1	$9K	Buy	107 +5	+5%	+$496	﹤0.01%	315
2020 Q4	$10K	Buy	+102	New	+$8.13K	﹤0.01%	277

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

Global Wealth Management Investment Advisory's ARKG Position: Q3 2023 in Review

Global Wealth Management Investment Advisory sold out of ARK Genomic Revolution ETF (ARKG) in Q3 2023, closing a stake of 5 shares — an estimated $170 sold.

Global Wealth Management Investment Advisory first reported a position in ARKG in Q4 2020 and held it in 8 quarters. The position peaked at $10K in Q2 2021. 287 funds tracked by Wall St. Rank hold ARKG as of Q3 2023.

Global Wealth Management Investment Advisory reported no remaining ARK Genomic Revolution ETF position as of Q3 2023 after selling out during the quarter.
Global Wealth Management Investment Advisory sold 5 ARK Genomic Revolution ETF shares in Q3 2023, an estimated $170.
Global Wealth Management Investment Advisory first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 8 quarters.
Global Wealth Management Investment Advisory's ARK Genomic Revolution ETF position peaked at $10K in Q2 2021.
287 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2023.

Based on Global Wealth Management Investment Advisory's 13F filing for Q3 2023, filed 6 Nov 2023.